sulfinpyrazone has been researched along with Angiohemophilia in 1 studies
Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morin, RJ | 1 |
| Chen, AF | 1 |
| Narayanan, AS | 1 |
| Raye, C | 1 |
| Moss, RA | 1 |
| Srikantaiah, MV | 1 |
| Barajas, L | 1 |
1 other study available for sulfinpyrazone and Angiohemophilia
| Article | Year |
|---|---|
Platelet adhesion to collagen in normal and von Willebrand's disease subjects.
Topics: Animals; Aspirin; Blood Platelets; Collagen; Diabetes Mellitus; Dipyridamole; Factor VIII; Humans; K | 1980 |